Physician-guided GLP-1 treatments personalized to your body. Delivered discreetly to your door. No clinics. No judgment. Just results.
Our Treatments
Science-backed, physician-prescribed GLP-1 treatments tailored to your body and goals.
Semaglutide is a GLP-1 receptor agonist that works by mimicking a natural hormone in your body to regulate appetite and blood sugar. It signals your brain to feel full sooner, reduces food cravings, and slows digestion — making it easier to eat less without feeling deprived. Clinically proven in large-scale trials, semaglutide consistently delivers meaningful, sustained weight loss when combined with lifestyle guidance from your care team.
Once-weekly subcutaneous injection, self-administered at home with a small pen needle. Simple and virtually painless.
Clinical trials show an average loss of ~0.5–1 lb per week, with up to 15% total body weight lost over 68 weeks.
In the STEP trials, patients lost an average of 14.9% of body weight — far exceeding diet and exercise alone.
Most patients follow a 6–12 month program with gradual dose escalation. Many continue long-term for weight maintenance.
Tirzepatide is a next-generation dual GIP/GLP-1 receptor agonist — the first of its kind. By activating two complementary metabolic pathways simultaneously, it delivers superior appetite suppression, improved insulin sensitivity, and accelerated fat loss compared to single-agonist therapies. If you're looking for the most powerful medically supervised weight loss option available today, tirzepatide represents the cutting edge of obesity medicine.
Once-weekly subcutaneous injection, self-administered at home. Dose is gradually increased over weeks for optimal tolerability.
Clinical data shows an average of ~0.7–1.3 lbs per week, with up to 22.5% total body weight lost at the highest dose.
In the SURMOUNT-1 trial, participants lost an average of 20.9% body weight — the highest ever recorded in a weight loss medication trial.
Typically a 6–12 month structured program. Dose escalation takes 5–20 weeks; most patients see peak results by month 9–12.
*First month pricing on qualifying plans. Compounded medications not FDA-approved. Rx required.
How It Works
Four simple steps — all from the comfort of your home.
Tell us your goals, health history, and lifestyle in 5 minutes.
A licensed physician creates your personalized plan within 24h.
Ships from an FDA-registered pharmacy in discreet packaging.
Regular check-ins and dosage adjustments keep you on track.
Thousand Patients
% Satisfaction
Avg. Weight Loss
States Covered
FAQ
Everything you need to know before getting started.
Semaglutide activates a single GLP-1 receptor pathway to reduce appetite and regulate blood sugar. Tirzepatide activates two pathways — GLP-1 and GIP — simultaneously, which generally produces greater weight loss. Clinical trials show tirzepatide patients lose up to 22.5% of body weight vs. ~15% with semaglutide. Your physician will recommend the right option based on your health profile and goals.
Most adults with a BMI of 27 or above — especially those with weight-related conditions like high blood pressure, type 2 diabetes, or high cholesterol — are strong candidates. A licensed physician will review your full health history before prescribing anything.
No — everything is 100% online. Complete a health questionnaire, get matched with a licensed physician, and your medication ships directly to your door from an FDA-registered pharmacy.
Most patients notice reduced appetite within 1–2 weeks of starting treatment. Visible weight loss typically begins by week 4–8. Results accelerate as your dose is gradually increased over the following months.
The most common side effects are mild and gastrointestinal — nausea, constipation, or mild stomach discomfort — especially during the dose escalation phase. These typically subside as your body adjusts. Your physician will monitor your progress and can adjust dosing to minimize discomfort.
Fully HIPAA-compliant with encrypted medical records and secure data handling. Your medication ships in plain, discreet packaging with no branding on the outside. Cancel anytime — no contracts, no surprise charges.
Our compounded GLP-1 medications are not typically covered by insurance, but they are eligible for FSA and HSA reimbursement. Our transparent pricing is designed to be significantly more affordable than brand-name alternatives.
Compounded semaglutide and tirzepatide are not FDA-approved drugs. They are compounded at FDA-registered, state-licensed pharmacies and are prescribed at the sole discretion of a licensed healthcare provider based on an individualized patient assessment. Compounded medications are not the same as FDA-approved branded medications (e.g., Ozempic®, Wegovy®, Mounjaro®, Zepbound®).
Individual results vary. Weight loss claims are based on published clinical trial data and average patient outcomes; your results may differ based on your health history, adherence to the prescribed protocol, diet, and physical activity. No outcome is guaranteed.
This website does not constitute medical advice and is for informational purposes only. Use of this website does not create a physician-patient relationship. Always consult a qualified healthcare professional before starting any new treatment or medication.
GLP-1 therapy is not appropriate for everyone. It is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and in those who are pregnant or breastfeeding. Your prescribing physician will review your complete health history prior to any prescription.
Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective manufacturers. RevitalCareRx, LLC is not affiliated with or endorsed by any branded medication manufacturer.
Ready?
Take a 5-minute consultation. A licensed physician creates your personalized plan — no commitment required.